BackStoke Therapeutics Overview

Stoke Therapeutics Current Cash

Latest current cash for STOK: $160M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$155.66M
43.36% YoYΔ $-119.16M vs prior year quarter

Peer average

Loading

Stoke Therapeutics Current Cash History

Loading

Stoke Therapeutics vs. peers: Current Cash Comparison

Loading

Stoke Therapeutics Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Stoke Therapeutics (STOK) FAQ

As of the most recent data (March 2026), STOK shows a current cash of $160M. That compares with $270M in the prior-year period — down 43.4% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, STOK's current cash is now $160M (was $270M) — a 43.4% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Stoke Therapeutics is outperforming or lagging.

Tracking STOK's current cash over time shows whether Stoke Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $160M That compares with $270M in the prior-year period — down 43.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has Stoke Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $160M) with ownership activity and broader fundamentals.

Stoke Therapeutics's current cash is $160M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.